Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

Quality, not quantity, will drive the next wave of partnerships and product launches.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

An analysis of annual premiums by federal poverty level.

Practice Leader, Oliver Wyman Actuarial Consulting

Diversity as a Strategic Priority

How can your I&D goals thrive? Walk the talk, says Florida Blue's CEO.

President and CEO, Florida Blue
CEO, Health Evolution
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Fourteen percent of physicians offer virtual visits. But a new CMS rule may make telehealth more commonplace.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.

Partner, Health & Life Sciences, Oliver Wyman
Senior Knowledge Expert, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

27 partnered products were launched last year, with 70 percent joint ventured or co-branded insurance products.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

The impact of the 2019 ACA's HIT moratorium on Medicare Advantage premiums.

Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

A closer look at why only 30 percent of C-suite teams and 13 percent of CEOs are women.

This year's hottest podcast conversations feature companies both in and out of healthcare on industry transformation.

Our most popular articles of the year offered our predictions on disruption and the future market, and highlighted our views on healthcare reform, ACOs, and much more.

Insights in your inbox

Subscribe